The DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Open accessAbstract
The macrophage is a key cell in the pro- and anti-inflammatory response including that of the inflammatory microenvironment of malignant tumors. Much current drug development in chronic inflammatory diseases and cancer therefore focuses on the macrophage as a target for immunotherapy. However, this strategy is complicated by the pleiotropic phenotype of the macrophage that is highly responsive to its microenvironment. The plasticity leads to numerous types of macrophages with rather different and, to some extent, opposing functionalities, as evident by the existence of macrophages with either stimulating or down-regulating effect on inflammation and tumor growth. The phenotypes are characterized by different surface markers and the present review describes recent progress in drug-targeting of the surface marker CD163 expressed in a subpopulation of macrophages. CD163 is an abundant endocytic receptor for multiple ligands, quantitatively important being the haptoglobin-hemoglobin complex. The microenvironment of inflammation and tumorigenesis is particular rich in CD163+ macrophages. The use of antibodies for directing anti-inflammatory (e.g., glucocorticoids) or tumoricidal (e.g., doxorubicin) drugs to CD163+ macrophages in animal models of inflammation and cancer has demonstrated a high efficacy of the conjugate drugs. This macrophage-targeting approach has a low toxicity profile that may highly improve the therapeutic window of many current drugs and drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–308 of 308
López‐Janeiro, Á., Padilla-Ansala, C., de Andrea, C. E., Hardisson, D., & Melero, I. (2020) · Modern Pathology · doi:10.1038/s41379-020-0534-z · Cited by 70
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
Stilund, M., Reuschlein, A., Christensen, T., Møller, H. J., Rasmussen, P. V., & Petersen, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098588 · Cited by 68
IL-17 induces macrophages to M2-like phenotype via NF-κB
Shen, J., Sun, X., Pan, B., Cao, S., Cao, J., Che, D., Liu, F., Zhang, S., & Yu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174899 · Cited by 68
Alisi, A. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.965 · Cited by 66
Andersen, M. N., Etzerodt, A., Graversen, J. H., Holthof, L. C., Moestrup, S. K., Hokland, M., & Møller, H. J. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02301-3 · Cited by 66
Self-citationProteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis
Fabriek, B. O., Møller, H. J., Vloet, R. P. M., van Winsen, L. M. L., Hanemaaijer, R., Teunissen, C. E., Uitdehaag, B. M. J., van den Berg, T. K., & Dijkstra, C. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.016 · Cited by 65
Rubio‐Navarro, A., Carril, M., Padró, D., Guerrero‐Hue, M., Tarín, C., Samaniego, R., Cannata, P., Cano, A., Amaro-Villalobos, J. M., Sevillano, Á., et al. (2016) · Theranostics · doi:10.7150/thno.14915 · Cited by 65
Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14474 · Cited by 65
Chen, T., Chen, J., Zhu, Y., Li, Y., Wang, Y., Chen, H., Wang, J., Li, X., Liu, Y., Li, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0515-6 · Cited by 65
Yuan, X., Ward, L. J., Forssell, C., Siraj, N., & Li, W. (2017) · Stroke · doi:10.1161/strokeaha.117.018724 · Cited by 64
Applying the 2017 McDonald diagnostic criteria for multiple sclerosis – Authors' reply
Thompson, A. J., Reingold, S. C., & Cohen, J. A. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30168-6 · Cited by 64
Feng, L., Zhou, X., Su, L., Feng, D., Jia, Y., & Xie, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038400 · Cited by 63
Kazankov, K., Tordjman, J., Møller, H. J., Vilstrup, H., Poitou, C., Bédossa, P., Bouillot, J., Clément, K., & Grønbæk, H. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12943 · Cited by 63
The blood transcriptome of childhood malaria
Boldt, A. B. W., Tong, H. V., Grobusch, M. P., Kalmbach, Y., Dzeing‐Ella, A., Kombila, M., Meyer, C. G., Kun, J. F. J., Kremsner, P. G., & Velavan, T. P. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.055 · Cited by 63
Beltrán, L. M., Múñoz‐Hernández, R., Pablo-Bernal, R. S. D., Morillo, J. S. G., Egido, J., Leal Noval, M., Ferrando‐Martínez, S., Blanco‐Colio, L. M., Genebat, M., Villar, J. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090541 · Cited by 62
Monocyte/macrophage‐derived soluble CD 163: a novel biomarker in multiple myeloma
Andersen, M. N., Abildgaard, N., Maniecki, M. B., Møller, H. J., & Andersen, N. F. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12296 · Cited by 62
Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma
Chen, X., Chen, J., Zhang, W., Sun, R., Liu, T., Zheng, Y., & Wu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22340 · Cited by 62
Greisen, S. R., Møller, H. J., Stengaard‐Pedersen, K., Hetland, M. L., Hørslev-Petersen, K., Jørgensen, A., Hvid, M., & Deleuran, B. W. (2011) · PubMed · Cited by 61
Gutiérrez, E., Egido, J., Rubio‐Navarro, A., Buendía, I., Blanco‐Colio, L. M., Toldos, Ó., Manzarbeitia, F., de Lorenzo, A., Sánchez, R., Ortíz, A., et al. (2012) · Nephron Clinical Practice · doi:10.1159/000342385 · Cited by 60
CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma
Yoon, D. H., Koh, Y. W., Kang, H. J., Kim, S., Park, C. S., Lee, S., Suh, C., & Huh, J. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01731.x · Cited by 60
Expression of CD163 in the liver of patients with viral hepatitis
Hiraoka, A., Horiike, N., Akbar, S. M. F., Michitaka, K., Matsuyama, T., & Onji, M. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.10.006 · Cited by 59
In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis
Moreno, J. A., Ortega‐Gómez, A., Delbosc, S., Beaufort, N., Sorbets, E., Louedec, L., Esposito‐Farèse, M., Tubach, F., Nicoletti, A., Steg, P. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr123 · Cited by 59
CD163 Immunohistochemistry Is Superior to CD68 in Predicting Outcome in Classical Hodgkin Lymphoma
Klein, J. L., Nguyen, T. T., Bien-Willner, G. A., Chen, L., Foyil, K. V., Bartlett, N. L., Duncavage, E. J., Hassan, A., Frater, J. L., & Kreisel, F. H. C. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp61tlmxlsljys · Cited by 58
Huang, Z., Xie, N., Liu, H., Wan, Y., Zhu, Y., Zhang, M., Tao, Y., Zhou, H., Liu, X., Hou, J., et al. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12927 · Cited by 58
Koh, Y. W., Park, C. S., Yoon, D. H., Suh, C., & Huh, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087066 · Cited by 57
Yu, Y., Ke, L., Lv, X., Ling, Y., Lu, J., Hu, L., Qiu, W., Huang, X.-J., Liu, G., Li, W., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167071 · Cited by 57
Kobayashi, Y., Yoshida, S., Nakama, T., Zhou, Y., Ishikawa, K., Arita, R., Nakao, S., Miyazaki, M., Sassa, Y., Oshima, Y., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305321 · Cited by 55
Serum levels of soluble CD163 in patients with systemic sclerosis
Nakayama, W., Jinnin, M., Makino, K., Kajihara, I., Makino, T., Fukushima, S., Inoue, Y., & Ihn, H. (2010) · Rheumatology International · doi:10.1007/s00296-010-1691-z · Cited by 54
Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease
Inamoto, Y., Martin, P. J., Paczesny, S., Tabellini, L., Momin, A. A., Mumaw, C. L., Flowers, M. E. D., Lee, S. J., Carpenter, P. A., Storer, B. E., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.04.019 · Cited by 54
Iacobaeus, E., Douagi, I., Jitschin, R., Marcusson‐Ståhl, M., Andrén, A. T., Gavin, C., Lefsihane, K., Davies, L. C., Mougiakakos, D., Kadri, N., et al. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12042 · Cited by 54
Llauradó, G., González-Clemente, J. M., Maymó‐Masip, E., Subías, D., Vendrell, J. J., & Chacón, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043919 · Cited by 51
Zhou, J. W., Zheng, S., Liu, T., Liu, Q., Chen, Y., Tan, D., Ma, R., & Lu, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26918 · Cited by 51
Franzè, E., Caruso, R., Stolfi, C., Sarra, M., Cupi, M. L., Caprioli, F., Monteleone, I., Zorzi, F., Nitto, D. D., Colantoni, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069839 · Cited by 50
Mueller, J. L., Feeney, E. R., Zheng, H., Misdraji, J., Kruger, A. J., Alatrakchi, N., King, L. Y., Gelrud, L. G., Corey, K. E., & Chung, R. T. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.36 · Cited by 50
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer
Cheng, Z., Zhang, D., Gong, B., Wang, P., & Liu, F. (2017) · Oncotarget · doi:10.18632/oncotarget.20244 · Cited by 50
Shabo, I., Olsson, H., Elkarim, R. A., Sun, X., & Svanvik, J. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0145-7 · Cited by 49
Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer
No, J. H., Moon, J. M., Kim, K., & Kim, Y.-B. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000349892 · Cited by 49
Weinberg, J. B., Volkheimer, A. D., Rubach, M. P., Florence, S. M., Mukemba, J. P., Kalingonji, A. R., Langelier, C., Chen, Y., Bush, M. A., Yeo, T. W., et al. (2016) · Scientific Reports · doi:10.1038/srep29151 · Cited by 49
Huang, X., Pan, Y., Ma, J., Kang, Z., Xu, X., Zhu, Y., Chen, J., Zhang, W., Chang, W., & Zhu, J. (2018) · Cancer Medicine · doi:10.1002/cam4.1420 · Cited by 49
Kather, J. N., Hörner, C., Weis, C., Aung, T., Vokuhl, C., Weiß, C., Scheer, M., Marx, A., & Simon‐Keller, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45551-y · Cited by 49
Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
Werner, L. C., Dreyer, J. H., Hartmann, D., Barros, M. H. M., Büttner-Herold, M. J., Grittner, U., & Niedobitek, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-66010-z · Cited by 49
Pillars Article: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J. Immunol. 2000. 164: 6166–6173
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701141 · Cited by 48
Tang, M., Liu, B., Bu, X., & Zhao, P. (2018) · Cancer Science · doi:10.1111/cas.13567 · Cited by 46
Lidofsky, A., Holmes, J. A., Feeney, E. R., Kruger, A. J., Salloum, S., Zheng, H., Seguin, I. S., Altınbaş, A., Masia, R., Corey, K. E., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy331 · Cited by 46
Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis
Maras, J. S., Das, S., Sharma, S. K., Baweja, S., Kumar, J., Vyas, A. K., Kumar, D., Bhat, A., Yadav, G., Choudhary, M. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28483-x · Cited by 45
Targeting Dexamethasone to Macrophages in a Porcine Endotoxemic Model
Granfeldt, A., Hvas, C. L., Graversen, J. H., Christensen, P. A., Petersen, M. D., Anton, G., Svendsen, P., Sølling, C. G., Etzerodt, A., Tønnesen, E., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828a45ef · Cited by 44
Self-citationEichendorff, S., Svendsen, P., Bender, D., Keiding, S., Christensen, E. I., Deleuran, B. W., & Moestrup, S. K. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0768-6 · Cited by 44
Self-citationSakumura, N., Shimizu, M., Mizuta, M., Inoue, N., Nakagishi, Y., & Yachie, A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.05.017 · Cited by 44
Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
Sablik, K. A., Jordanova, E. S., Pocorni, N., Groningen, M. C. C., & Betjes, M. G. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03106 · Cited by 44
Bari, M. F., Weickert, M. O., Sivakumar, K., James, S. G., Snead, D. R. J., Tan, B. K., Randeva, H. S., Bastie, C. C., & Vatish, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101327 · Cited by 43
Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
Sakamoto, S., Kagawa, S., Kuwada, K., Ito, A., Kajioka, H., Kakiuchi, Y., Watanabe, M., Kagawa, T., Yoshida, R., Kikuchi, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1671760 · Cited by 43
Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
Svendsen, P., Etzerodt, A., Deleuran, B. W., & Moestrup, S. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-69018-7 · Cited by 43
Self-citationHuang, H., Liu, X., Zhao, F., Lü, J., Bao, Z., Peng, X., Zhang, M., Chen, X., Li, G., & Li, X. (2017) · Acta Oto-Laryngologica · doi:10.1080/00016489.2017.1296585 · Cited by 42
Ma, C., Horlad, H., Ohnishi, K., Nakagawa, T., Yamada, S., Kitada, S., Motoshima, T., Kamba, T., Nakayama, T., Fujimoto, N., et al. (2017) · Medical Molecular Morphology · doi:10.1007/s00795-017-0165-8 · Cited by 42
Tiainen, S., Masarwah, A., Oikari, S., Rilla, K. J., Hämäläinen, K. M., Sudah, M., Sutela, A., Vanninen, R. L., Ikonen, J., Tammi, R., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05491-7 · Cited by 42
Dige, A. K., Støy, S. H., Thomsen, K. L., Hvas, C. L., Agnholt, J. S., Dahlerup, J. F., Møller, H. J., & Grønbæk, H. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12222 · Cited by 40
Dai, C., Yao, X., Gordon, E. M., Barochia, A. V., Cuento, R. A., Kaler, M. M., Meyer, K. S., Keeran, K. J., Nugent, G. Z., Jeffries, K. R., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.94 · Cited by 40
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Frantz, C., Pezet, S., Avouac, J., & Allanore, Y. (2018) · Disease Markers · doi:10.1155/2018/8509583 · Cited by 39
Dubayee, M. S. A., Alayed, H., Almansour, R., Alqaoud, N., Alnamlah, R., Obeid, D., Alshahrani, A. S., Zhra, M., Nasr, A., Al-Bawab, A., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00537 · Cited by 38
Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma
Zhou, L., Li, Y., Gao, W., Huangfu, H., Wen, S., Zhang, C., Zhao, Q., Dong, Z., Qu, C., Li, G., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02936-w · Cited by 38
El‐Asrar, A. M. A., Ahmad, A., Allegaert, E., Siddiquei, M. M., Gikandi, P. W., Hertogh, G. D., & Opdenakker, G. (2019) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2019.1616772 · Cited by 38
Zhu, H., Sun, X., Zhu, L., Hu, F., Shi, L., Li, Z., & Su, Y. (2014) · Journal of Immunology Research · doi:10.1155/2014/431896 · Cited by 36
Rafique, A., Etzerodt, A., Graversen, J. H., Moestrup, S. K., Dagnæs‐Hansen, F., & Møller, H. J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s192113 · Cited by 36
Self-citationWatson, C. J., Glezeva, N., Horgan, S. J., Gallagher, J., Phelan, D. M. J., McDonald, K., Tolan, M. J., Baugh, J. A., Collier, P. H., & Ledwidge, M. T. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013416 · Cited by 36
Maniecki, M. B., Etzerodt, A., Moestrup, S. K., Møller, H. J., & Graversen, J. H. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.02.001 · Cited by 35
Self-citationKowal‐Bielecka, O., Bielecki, M., Guiducci, S., Trzcińska-Butkiewicz, B., Michalska-Jakubus, M. M., Matucci‐Cerinic, M., Brzosko, M., Krasowska, D., Chyczewski, L., & Kowal, K. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4246 · Cited by 35
Kazankov, K., Rode, A., Simonsen, K., Villadsen, G. E., Nicoll, A., Møller, H. J., Lim, L., Angus, P., Kronborg, I., Arachchi, N., et al. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1099722 · Cited by 35
Barke, T. L., Goldstein, J., Sundermann, A., Reddy, A., Linder, J. E., Correa, H., Velez-Edwards, D., & Aronoff, D. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.13020 · Cited by 34
Monocyte CD163 is altered in association with diabetic complications: possible protective role
Min, D., Brooks, B. A., Wong, J., Aamidor, S. E., Seehoo, R., Sutanto, S., Harrisberg, B. P., Yue, D. K., Twigg, S. M., & McLennan, S. V. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1015-461rr · Cited by 32
Kawarabayashi, R., Motoyama, K., Nakamura, M., Yamazaki, Y., Morioka, T., Mori, K., Fukumoto, S., Imanishi, Y., Shioi, A., Shoji, T., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6549242 · Cited by 32
Nishino, A., Katsumata, Y., Kawasumi, H., Hirahara, S., Kawaguchi, Y., & Yamanaka, H. (2019) · Lupus · doi:10.1177/0961203319860201 · Cited by 32
Badmann, S., Heublein, S., Mayr, D. C., Reischer, A., Liao, Y., Kolben, T., Beyer, S., Hester, A., Zeder-Göß, C., Burges, A., et al. (2020) · Cells · doi:10.3390/cells9051224 · Cited by 32
Aota, K., Yamanoi, T., Kani, K., Nakashiro, K., Ishimaru, N., & Azuma, M. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12756 · Cited by 31
Wu, S., Xu, R., Li, X., Zhao, X., & Qian, B. (2018) · Oncotarget · doi:10.18632/oncotarget.25334 · Cited by 30
Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure
Ye, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i18.2818 · Cited by 29
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
Graversen, J. H., & Moestrup, S. K. (2015) · Membranes · doi:10.3390/membranes5020228 · Cited by 28
Self-citationKlimczak‐Tomaniak, D., Bouwens, E., Schuurman, A., Akkerhuis, K. M., Constantinescu, A. A., Brugts, J. J., Westenbrink, B. D., van Ramshorst, J., Germans, T., Pączek, L., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12678 · Cited by 28
Four genes relevant to pathological grade and prognosis in ovarian cancer
Pan, X., Chen, Y., & Gao, S. (2020) · Cancer Biomarkers · doi:10.3233/cbm-191162 · Cited by 28
Antibody combinations for optimized staining of macrophages in human lung tumours
Frafjord, A., Skarshaug, R., Hammarström, C. L., Stankovic, B., Dorg, L. T., Aamodt, H., Woldbæk, P. R., Helland, Å., Brustugun, O. T., Øynebråten, I., et al. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12889 · Cited by 27
Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats
Thomsen, K. L., Møller, H. J., Graversen, J. H., Magnusson, N. E., Moestrup, S. K., Vilstrup, H., & Grønbæk, H. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i17.726 · Cited by 26
Self-citationM2 macrophages predict worse long-term outcomes in human acute tubular necrosis
Kim, M.-G., Lim, K., Lee, Y. J., Yang, J., Oh, S. W., Cho, W.-Y., & Jo, S.-K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58725-w · Cited by 26
Pulmonary Haptoglobin and CD163 Are Functional Immunoregulatory Elements in the Human Lung
Abdullah, M., Kähler, D., Vock, C., Reiling, N., Kugler, C., Drömann, D., Rupp, J., Hauber, H. P., Fehrenbach, H., Zabel, P., et al. (2011) · Respiration · doi:10.1159/000329868 · Cited by 25
CD163‐positive macrophage infiltration predicts systemic involvement in sarcoidosis
Isohisa, T., Asai, J., Kanemaru, M., Arita, T., Tsutsumi, M., Kaneko, Y., Arakawa, Y., Wada, M., Konishi, E., & Katoh, N. (2020) · Journal of Cutaneous Pathology · doi:10.1111/cup.13675 · Cited by 23
Motta, A. C. F., Zhan, Q., Larson, A. R., Lerman, M. A., Woo, S., Soiffer, R. J., Gf, M., & Treister, N. S. (2017) · Oral Diseases · doi:10.1111/odi.12813 · Cited by 22
Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease
Daly, A. K., Walsh, C., Feighery, C., O’Shea, U., Jackson, J., & Whelan, A. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03012.x · Cited by 21
Mφller, L. N. O., Knudsen, A. R., Andersen, K. J., Nyengaard, J. R., Hamilton-Dutoit, S. J., Mφller, E. M. O., Svendsen, P., Møller, H. J., Moestrup, S. K., Graversen, J. H., et al. (2015) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2015.09.001 · Cited by 19
Self-citationFerumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection
Aghighi, M., Pisani, L. J., Theruvath, A. J., Muehe, A. M., Donig, J., Khan, R., Holdsworth, S. J., Kambham, N., Concepcion, W., Grimm, P. C., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1084-8 · Cited by 19
Lee, W. J., Lee, M. H., Kim, H. T., Won, C. H., Lee, M. W., Choi, J. H., & Chang, S. E. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000549 · Cited by 19
Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis
Kempf, W., Zollinger, T., Sachs, M., Ullmer, E., Cathomas, G., Dirnhofer, S., & Mertz, K. D. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.07.011 · Cited by 18
Tsuda, S., Carreras, J., Kikuti, Y. Y., Nakae, H., Dekiden‐Monma, M., Imai, J., Tsuruya, K., Nakamura, J., Tsukune, Y., Uchida, T., et al. (2019) · Pathology International · doi:10.1111/pin.12794 · Cited by 18
Gao, J., Ren, Y., Guo, H., Mao, R., Xie, H., Su, H., She, Y., Deng, J., Yang, M., Han, B., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.113 · Cited by 18
Tantawy, A. A. G., Adly, A. A. M., & Ismail, E. A. R. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283573a42 · Cited by 17
Hu, W., Scott, A., WOLFE, N. D., Singh, S., Jedlicka, A., & Bourgeois, A. L. (2011) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.03.013 · Cited by 17
Yang, G., Zhang, L., Liu, M., Liu, Q., Duan, X., & Bo, J. (2019) · World Journal of Urology · doi:10.1007/s00345-018-02618-1 · Cited by 15
Otsuka, F., Zhao, X., Trout, H. H., Qiao, Y., Wasserman, B. A., Nakano, M., Macphee, C. H., Brandt, M. A., Krug‐Gourley, S., Guo, L., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.014 · Cited by 14
Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas
Roussel, M., Lhomme, F., Roe, C. E., Bartkowiak, T., Gravelle, P., Laurent, C., Fest, T., & Irish, J. M. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02464-z · Cited by 14
Xu, J., Wang, W., Zhou, J., Liu, C., Shi, J.-L., Lu, P., & Ding, J. (2019) · Pancreas · doi:10.1097/mpa.0000000000001364 · Cited by 13
Zhang, Y., Ma, Y., Zhang, C., et al. (2015) · Viral Immunology · doi:10.1089/vim.2014.0112 · Cited by 12
Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren's disease
Li, J., Yu, Y., Liu, C.-H., & Wang, C.-M. (2018) · Renal Failure · doi:10.1080/0886022x.2018.1518242 · Cited by 12
Kowal, K., Moniuszko, M., & Bodzenta‐Łukaszyk, A. (2014) · PubMed · Cited by 11
Liu, H., Lin, D., Xiang, H., Chen, W., Zhao, S., Peng, H., Yang, J., Chen, P., Chen, S., & Lü, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4600 · Cited by 11
Svart, M. V., Rittig, N. F., Møller, N., Møller, H. J., & Grønbæk, H. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12869 · Cited by 11
CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients
Ahmed, H. A. S., Raslan, W. F., Deifalla, A., & Fathallah, M. D. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1850 · Cited by 11
Sato, T., Kameyama, T., Noto, T., Ueno, H., & Inoue, H. (2015) · International Heart Journal · doi:10.1536/ihj.14-224 · Cited by 8
Foks, M., Wągrowska‐Danilewicz, M., Danilewicz, M., Bonczysta, M., Olborski, B., & Stasikowska‐Kanicka, O. (2019) · Polish Journal of Pathology · doi:10.5114/pjp.2019.90399 · Cited by 7
Kobayashi, M., Matsumoto, Y., Satomi, H., Tateishi, A., Ohya, M., Ito, I., & Kanno, H. (2020) · Immunologic Research · doi:10.1007/s12026-020-09140-w · Cited by 6
Anti-inflammatory liposomes have no impact on liver regeneration in rats
Jepsen, B. N., Andersen, K. J., Knudsen, A. R., Nyengaard, J. R., Hamilton-Dutoit, S. J., Svendsen, P., Etzerodt, A., Møller, H. J., Moestrup, S. K., Graversen, J. H., et al. (2015) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2015.10.018 · Cited by 5
Self-citationA Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
Farrokhi, M., Saadatpour, Z., Fadaee, E., Saadatpour, L., Rezaei, A., Moeini, P., & Amani-Beni, A. (2016) · PubMed · Cited by 5
Cited by
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Zhang, Q., & Sioud, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087493 · Cited by 300
Kohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Liu, Z., Li, G., Li, X., Wang, Y., Liao, L., Yang, T., Han, C., Huang, K., Chen, C., Li, X., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106093 · Cited by 7
Metadata
- Authors
- Skytthe, M. K., Graversen, J. H., & Moestrup, S. K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-31
- Volume
- 21
- Issue
- 15
- Pages
- 5497
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3046770314
- Cited by
- 261
- References
- 308
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.